OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients
Rieke Alten, Gerd R Burmester, Marco Matucci‐Cerinic, et al.
Rheumatology and Therapy (2023) Vol. 10, Iss. 6, pp. 1575-1595
Open Access | Times Cited: 6
Rieke Alten, Gerd R Burmester, Marco Matucci‐Cerinic, et al.
Rheumatology and Therapy (2023) Vol. 10, Iss. 6, pp. 1575-1595
Open Access | Times Cited: 6
Showing 6 citing articles:
Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis
Peter Youssef, Sabina Ciciriello, Talib Tahir, et al.
Rheumatology and Therapy (2025)
Open Access
Peter Youssef, Sabina Ciciriello, Talib Tahir, et al.
Rheumatology and Therapy (2025)
Open Access
Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis
Blanca Hernández‐Cruz, Uta Kiltz, Jérôme Avouac, et al.
Rheumatology and Therapy (2023) Vol. 10, Iss. 6, pp. 1417-1457
Open Access | Times Cited: 9
Blanca Hernández‐Cruz, Uta Kiltz, Jérôme Avouac, et al.
Rheumatology and Therapy (2023) Vol. 10, Iss. 6, pp. 1417-1457
Open Access | Times Cited: 9
Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: results of a long-term study
Roberto Caporali, Peter C. Taylor, Daniel Aletaha, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 10, pp. 2799-2809
Open Access | Times Cited: 1
Roberto Caporali, Peter C. Taylor, Daniel Aletaha, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 10, pp. 2799-2809
Open Access | Times Cited: 1
Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational Study
Peter C. Taylor, Walid Fakhouri, S. Ogwu, et al.
Rheumatology and Therapy (2024)
Open Access
Peter C. Taylor, Walid Fakhouri, S. Ogwu, et al.
Rheumatology and Therapy (2024)
Open Access
Characteristics of clinical manifestations and pharmacotherapy in patients with rheumatoid arthritis requiring switching between biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors
А. O. Bobkova, А. М. Лила, А. Е. Каратеев
Modern Rheumatology Journal (2024) Vol. 18, Iss. 4, pp. 16-22
Open Access
А. O. Bobkova, А. М. Лила, А. Е. Каратеев
Modern Rheumatology Journal (2024) Vol. 18, Iss. 4, pp. 16-22
Open Access
Efficacy and safety of baricitinib in rheumatoid arthritis patients with moderate renal impairment: a multicenter propensity score matching study
Akira Maeyama, Masakazu Kondo, Hiroshi Harada, et al.
BMC Rheumatology (2024) Vol. 8, Iss. 1
Open Access
Akira Maeyama, Masakazu Kondo, Hiroshi Harada, et al.
BMC Rheumatology (2024) Vol. 8, Iss. 1
Open Access
